TissGeneSummary for RFPL4B |
Gene summary |
Basic gene information | Gene symbol | RFPL4B |
Gene name | ret finger protein-like 4B | |
Synonyms | RNF211 | |
Cytomap | UCSC genome browser: 6q21 | |
Type of gene | protein-coding | |
RefGenes | NM_001013734.2, | |
Description | RING finger protein 211 | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000251258 | ||
HPRD : 18472 | ||
Vega : OTTHUMG00000015390 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_RFPL4B | |
BioGPS: 442247 | ||
Pathway | NCI Pathway Interaction Database: RFPL4B | |
KEGG: RFPL4B | ||
REACTOME: RFPL4B | ||
Pathway Commons: RFPL4B | ||
Context | iHOP: RFPL4B | |
ligand binding site mutation search in PubMed: RFPL4B | ||
UCL Cancer Institute: RFPL4B | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of RFPL4B | ||
Description by TissGene annotations | TissgsKTS CNV lost TissGeneKTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for RFPL4B |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KICH | -2.3560266 | 0.0101094 | -2.366136 | 5.23E-11 | 4.33E-10 |
LIHC | -0.2188566 | -2.2831746 | 2.064318 | 6.13E-06 | 2.72E-05 |
Top |
TissGene-miRNA for RFPL4B |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for RFPL4B |
TissGeneSNV for RFPL4B |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.D125N | UCEC | 1 |
p.P166Q | HNSC | 1 |
p.E239K | SKCM | 1 |
p.P199T | STAD | 1 |
p.R205C | COAD | 1 |
p.D125Y | LUAD | 1 |
p.K156T | STAD | 1 |
p.H85N | HNSC | 1 |
p.L80R | STAD | 1 |
p.R205C | GBM | 1 |
p.D16N | SKCM | 1 |
p.R203H | CESC | 1 |
p.F245L | BLCA | 1 |
p.E41X | COAD | 1 |
p.V223I | COAD | 1 |
p.G253R | SKCM | 1 |
p.H190D | LUSC | 1 |
p.A47V | STAD | 1 |
p.D173N | UCEC | 1 |
p.E217* | UCS | 1 |
p.D125N | SKCM | 1 |
p.R94W | STAD | 1 |
p.L90F | SKCM | 1 |
p.A133D | COAD | 1 |
p.D125E | LIHC | 1 |
p.N225K | LUAD | 1 |
p.R205C | SKCM | 1 |
p.D129G | COAD | 1 |
p.E89K | SKCM | 1 |
p.D129Y | HNSC | 1 |
p.E88K | SKCM | 1 |
p.E217X | UCS | 1 |
p.M184T | UCEC | 1 |
p.Q65K | CESC | 1 |
p.E165K | SKCM | 1 |
p.R205G | BLCA | 1 |
p.G253E | UCEC | 1 |
p.S159F | PAAD | 1 |
p.I39M | COAD | 1 |
p.L114V | CESC | 1 |
p.R53* | LUAD | 1 |
p.P139S | SKCM | 1 |
p.K185N | READ | 1 |
p.R94W | SKCM | 1 |
p.G234S | SKCM | 1 |
p.L24V | STAD | 1 |
p.R79Q | UCEC | 1 |
p.V29M | STAD | 1 |
p.L240V | STAD | 1 |
p.R79Q | BLCA | 1 |
p.R53Q | SKCM | 1 |
p.D129N | SKCM | 1 |
Top |
TissGeneCNV for RFPL4B |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for RFPL4B |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for RFPL4B |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for RFPL4B |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for RFPL4B |
TissGeneDrug for RFPL4B |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for RFPL4B |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |